Drug Development and Industrial Pharmacy · 1981 · 197 citations · 20 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryParenteral Dosage FormsParenteral Drug DeliveryDrug Delivery BiomaterialsDrug Delivery SystemsIntravenous Drug DeliveryParenteral FormulationsPolymeric Carrier SystemsPolymeric Drug Delivery SystemsBiocompatible MaterialsBiodegradable Delivery MaterialsBiodegradable Drug CarriersBiodegradable Polymer CarriersControlled ReleaseParenteral Drug AdministrationRoom-temperature StorageViscosity
A new dosage form designed to provide parenteral drug delivery over a prolonged period of time following a standard injection has been investigated using testosterone as the model drug. The drug carrier consists of a biodegradable, biocompatible polymer in which the drug is dispersed on a molecular level. The polymer itself is formulated as a pseudolatex with high solid content (40.0%). The formulation has a low viscosity (97 cps) which can be injected easily through a hypodermic needle. The histopathology study showed good tissue compatibility of the pseudolatices and in-vivo tests on rats confirmed a prolonged release of drug over a 14 day period. The stability of the biodegradable poly-d, l-lactic acid latex was found not to be significantly changed over 120 days of storage at room temperature (25°). A six month study showed a slight increase (10%) in the viscosity of the parenteral product when stored at room temperature. The increase was attributed to partial coalescence of the polymer particles which had an initial diameter of 0.45 μm.
20
Polylactic Acid for Surgical Implants
R. K. Kulkarni · Archives of Surgery · 1966 · 836 citations
Biodegradable poly(lactic acid) polymers
R. K. Kulkarni, Evan G. Moore, Andrew F. Hegyeli et al. · Journal of Biomedical Materials Research · 1971 · 798 citations
Robert A. Miller, John M. Brady, Duane E. Cutright · Journal of Biomedical Materials Research · 1977 · 714 citations
Natural Sciences, Biomedical Engineering, Biocompatibility +14